Ashurst, led by corporate partner Stephen Lloyd, advised Nomura as leader of a £25m investment in UK-based biotechnology company Chroma Therapeutics. Wragge & Co, led by corporate associate Ian Piggin, advised Chroma Therapeutics.
Taylor Wessing, led by intellectual property (IP) partner Malcolm Bates, has advised Marseille-based biotechnology company Innate Pharma on its partnership with Danish global healthcare company Novo Nordisk, which will see Novo Nordisk invest 10m (£6.9m) into the French firm. Kramer Levin Naftalis & Frankel, led by New York-based IP partner Paul Connuck, advised Novo Nordisk.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
